NCT07208799View on ClinicalTrials.gov

COMPARISON OF EFFECTIVENESS OF SUBMUCOSAL DEXAMETHASONE AND METHYLPREDNISOLONE IN MANAGEMENT OF POST OPERATIVE SEQUELAE IN MANDIBULAR PARASYMPHYSIS FRACTURES

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

November 1, 2026

Conditions
Mandible FractureEdema FacePain ManagementCorticosteroid Injection
Interventions
DRUG

Dexamethasone

single dose of dexamethasone 8 mg (2 mL) administered submucosally at the surgical site 30 minutes before incision.

DRUG

Methylprednisolone (Corticosteroid)

a single dose of methylprednisolone 40 mg (2 mL) will be administered submucosally at the surgical site 30 minutes before incision.

All Listed Sponsors
lead

Nishtar Medical University

OTHER